Omar Ali
Advisor on value Based Pricing, US Embassy, Lecturer Value Based Pricing & Outcomes Based Innovative Contracting, University of Portsmouth & Former Member Adoption & Impact Panel, NICE
University of Portsmouth
Check out the incredible speaker line-up to see who will be joining Omar.
Download The Latest Agenda
Biosimilars Commercialisation Summit Agenda 2019
Conference Day Two
Thursday, March 5th, 2020
12:00 PM Payer Perspectives on Value Drivers for Biosimilars
- Undertake a Healthcare Fiscal overview, exploring the medicine funding landscape for biosimilars and the New NHS CQUINS on Biosimilars and its implementation
- Hear how payers are aligning biosimilars with innovative parent brands to streamline patient care settings
- Consider what the differential payer value drivers are for switching from parent brand to biosimilar, compared to biosimilar to biosimilar
- Bridge the uncertainty gap between payers &pharma – the shifting paradigm
1:40 PM Value Based Agreements with Biosimilars
- Gain a comprehensive knowledge of what a value based agreement is and its significance to the biosimilars industry
- Learn how to construct your own value based agreement
- Explore both market access and payer perspectives on risk sharing
3:25 PM Panel Discussion: The Market Value of Real World Evidence in the Education of Stakeholders
- Explore the contentious idea that real world evidence is an unnecessary undertaking in the commercialisation of biosimilars
- Consider the pros and cons of incremental registration for multiple indications
- Hear the views of a sponsoring company, pharmacist, and payer